| Year |
Citation |
Score |
| 2021 |
Laurent C, Deblois G, Clénet ML, Carmena Moratalla A, Farzam-Kia N, Girard M, Duquette P, Prat A, Larochelle C, Arbour N. Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33323466 DOI: 10.1212/NXI.0000000000000931 |
0.56 |
|
| 2020 |
Bovis F, Kalincik T, Lublin F, Cutter G, Malpas C, Horakova D, Havrdova EK, Trojano M, Prat A, Girard M, Duquette P, Onofrj M, Lugaresi A, Izquierdo G, Eichau S, et al. Treatment response score to glatiramer acetate or interferon beta-1a. Neurology. PMID 33024022 DOI: 10.1212/WNL.0000000000010991 |
0.56 |
|
| 2020 |
Broux B, Zandee S, Gowing E, Charabati M, Lécuyer MA, Tastet O, Hachehouche L, Bourbonnière L, Ouimet JP, Lemaitre F, Larouche S, Cayrol R, Bouthillier A, Moumdjian R, Lahav B, ... ... Prat A, et al. Interleukin-26, preferentially produced by T17 lymphocytes, regulates CNS barrier function. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32788322 DOI: 10.1212/NXI.0000000000000870 |
0.8 |
|
| 2020 |
Lizak N, Malpas CB, Sharmin S, Havrdova EK, Horakova D, Izquierdo G, Eichau S, Lugaresi A, Duquette P, Girard M, Prat A, Larochelle C, Trojano M, Grand'Maison F, Grammond P, et al. Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis. Jama Neurology. PMID 32716480 DOI: 10.1001/jamaneurol.2020.2453 |
0.56 |
|
| 2020 |
Le M, Malpas C, Sharmin S, Horáková D, Havrdova E, Trojano M, Izquierdo G, Eichau S, Ozakbas S, Lugaresi A, Prat A, Girard M, Duquette P, Larochelle C, Alroughani R, et al. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520926955. PMID 32538713 DOI: 10.1177/1352458520926955 |
0.56 |
|
| 2020 |
Ayrignac X, Larochelle C, Keezer M, Roger E, Poirier J, Lahav B, Girard M, Prat A, Duquette P. Frailty in ageing persons with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520923945. PMID 32458728 DOI: 10.1177/1352458520923945 |
0.56 |
|
| 2020 |
Ayrignac X, Letourneau-Guillon L, Carra-Dallière C, Duquette P, Girard M, Poirier J, Lahav B, Larochelle C, Prat A. From Baló's concentric sclerosis to multiple sclerosis: a series of 6 patients. Multiple Sclerosis and Related Disorders. 42: 102078. PMID 32408148 DOI: 10.1016/j.msard.2020.102078 |
0.56 |
|
| 2020 |
Malpas CB, Manouchehrinia A, Sharmin S, Roos I, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Eichau S, Bergamaschi R, Sola P, Ferraro D, Lugaresi A, Prat A, Girard M, et al. Early clinical markers of aggressive multiple sclerosis. Brain : a Journal of Neurology. PMID 32386427 DOI: 10.1093/brain/awaa081 |
0.56 |
|
| 2020 |
He A, Merkel B, Brown JWL, Zhovits Ryerson L, Kister I, Malpas CB, Sharmin S, Horakova D, Kubala Havrdova E, Spelman T, Izquierdo G, Eichau S, Trojano M, Lugaresi A, Hupperts R, ... ... Prat A, et al. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study. The Lancet. Neurology. 19: 307-316. PMID 32199096 DOI: 10.1016/S1474-4422(20)30067-3 |
0.56 |
|
| 2020 |
Antel JP, Becher B, Ludwin SK, Prat A, Quintana FJ. Glial Cells as Regulators of Neuroimmune Interactions in the Central Nervous System. Journal of Immunology (Baltimore, Md. : 1950). 204: 251-255. PMID 31907266 DOI: 10.4049/jimmunol.1900908 |
0.36 |
|
| 2019 |
Michel L, Grasmuck C, Charabati M, Lécuyer MA, Zandee S, Dhaeze T, Alvarez JI, Li R, Larouche S, Bourbonnière L, Moumdjian R, Bouthillier A, Lahav B, Duquette P, Bar-Or A, ... ... Prat A, et al. Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers. Science Translational Medicine. 11. PMID 31723036 DOI: 10.1126/scitranslmed.aaw0475 |
0.56 |
|
| 2019 |
Fambiatos A, Jokubaitis V, Horakova D, Kubala Havrdova E, Trojano M, Prat A, Girard M, Duquette P, Lugaresi A, Izquierdo G, Grand'Maison F, Grammond P, Sola P, Ferraro D, Alroughani R, et al. Risk of secondary progressive multiple sclerosis: A longitudinal study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519868990. PMID 31397221 DOI: 10.1177/1352458519868990 |
0.56 |
|
| 2019 |
Takenaka MC, Gabriely G, Rothhammer V, Mascanfroni ID, Wheeler MA, Chao CC, Gutiérrez-Vázquez C, Kenison J, Tjon EC, Barroso A, Vandeventer T, de Lima KA, Rothweiler S, Mayo L, Ghannam S, ... ... Prat A, et al. Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nature Neuroscience. PMID 31197266 DOI: 10.1038/s41593-019-0446-8 |
0.32 |
|
| 2019 |
Ayrignac X, Bilodeau PA, Prat A, Girard M, Labauge P, Le Lorier J, Larochelle C, Duquette P. Assessing the risk of multiple sclerosis disease-modifying therapies. Expert Review of Neurotherapeutics. PMID 31195842 DOI: 10.1080/14737175.2019.1627201 |
0.56 |
|
| 2019 |
Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, et al. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. Jama. 321: 175-187. PMID 30644981 DOI: 10.1001/jama.2018.20588 |
0.56 |
|
| 2019 |
Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, et al. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30636699 DOI: 10.1136/jnnp-2018-319831 |
0.56 |
|
| 2019 |
Dhaeze T, Tremblay L, Lachance C, Peelen E, Zandee S, Grasmuck C, Bourbonnière L, Larouche S, Ayrignac X, Rébillard RM, Poirier J, Lahav B, Duquette P, Girard M, Moumdjian R, ... ... Prat A, et al. CD70 defines a subset of proinflammatory and CNS-pathogenic T1/T17 lymphocytes and is overexpressed in multiple sclerosis. Cellular & Molecular Immunology. PMID 30635649 DOI: 10.1038/s41423-018-0198-5 |
0.56 |
|
| 2019 |
Nguyen AL, Havrdova EK, Horakova D, Izquierdo G, Kalincik T, van der Walt A, Terzi M, Alroughani R, Duquette P, Girard M, Prat A, Boz C, Sola P, Ferraro D, Lugaresi A, et al. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study. Multiple Sclerosis and Related Disorders. 28: 235-243. PMID 30623864 DOI: 10.1016/j.msard.2019.01.003 |
0.56 |
|
| 2018 |
Lorscheider J, Kuhle J, Izquierdo G, Lugaresi A, Havrdova E, Horakova D, Hupperts R, Duquette P, Girard M, Prat A, Grand'Maison F, Grammond P, Sola P, Ferraro D, Trojano M, et al. Anti-inflammatory disease modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study. European Journal of Neurology. PMID 30298572 DOI: 10.1111/ene.13824 |
0.56 |
|
| 2018 |
Hughes J, Jokubaitis V, Lugaresi A, Hupperts R, Izquierdo G, Prat A, Girard M, Duquette P, Grand'Maison F, Grammond P, Sola P, Ferraro D, Ramo-Tello C, Trojano M, Slee M, et al. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis. Jama Neurology. PMID 30083762 DOI: 10.1001/jamaneurol.2018.2109 |
0.56 |
|
| 2018 |
Kebir H, Carmant L, Fontaine F, Béland K, Bosoi CM, Sanon NT, Alvarez JI, Desgent S, Pittet CL, Hébert D, Langlois MJ, Rébillard RM, Nguyen DK, Cieuta-Walti C, Holmes GL, ... ... Prat A, et al. Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis. The Journal of Clinical Investigation. PMID 29629902 DOI: 10.1172/JCI97098 |
0.44 |
|
| 2017 |
Kalincik T, Manouchehrinia A, Sobisek L, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Izquierdo G, Lugaresi A, Girard M, Prat A, Duquette P, Grammond P, Sola P, et al. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response. Brain : a Journal of Neurology. 140: 2426-2443. PMID 29050389 DOI: 10.1093/brain/awx185 |
0.56 |
|
| 2017 |
Kalincik T, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Lechner-Scott J, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Solaro C, Grand'Maison F, Hupperts R, et al. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517728812. PMID 28857680 DOI: 10.1177/1352458517728812 |
0.56 |
|
| 2017 |
Lorscheider J, Jokubaitis VG, Spelman T, Izquierdo G, Lugaresi A, Havrdova E, Horakova D, Trojano M, Duquette P, Girard M, Prat A, Grand'Maison F, Grammond P, Pucci E, Boz C, et al. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS. Neurology. PMID 28794248 DOI: 10.1212/WNL.0000000000004330 |
0.56 |
|
| 2017 |
Ifergan I, Davidson TS, Kebir H, Xu D, Palacios-Macapagal D, Cann J, Rodgers JM, Hunter ZN, Pittet CL, Beddow S, Jones CA, Prat A, Sleeman MA, Miller SD. Targeting the GM-CSF receptor for the treatment of CNS autoimmunity. Journal of Autoimmunity. PMID 28641926 DOI: 10.1016/j.jaut.2017.06.005 |
0.8 |
|
| 2017 |
Signori A, Izquierdo G, Lugaresi A, Hupperts R, Grand'Maison F, Sola P, Horakova D, Havrdova E, Prat A, Girard M, Duquette P, Boz C, Grammond P, Terzi M, Singhal B, et al. Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517703800. PMID 28382837 DOI: 10.1177/1352458517703800 |
0.56 |
|
| 2017 |
Lühder F, Kebir H, Odoardi F, Litke T, Sonneck M, Alvarez JI, Winchenbach J, Eckert N, Hayardeny L, Sorani E, Lodygin D, Flügel A, Prat A. Laquinimod enhances central nervous system barrier functions. Neurobiology of Disease. PMID 28235673 DOI: 10.1016/j.nbd.2017.02.002 |
0.44 |
|
| 2017 |
Kalincik T, Brown JW, Robertson N, Willis M, Scolding N, Rice CM, Wilkins A, Pearson O, Ziemssen T, Hutchinson M, McGuigan C, Jokubaitis V, Spelman T, Horakova D, Havrdova E, ... ... Prat A, et al. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. The Lancet. Neurology. PMID 28209331 DOI: 10.1016/S1474-4422(17)30007-8 |
0.56 |
|
| 2016 |
Kuhlmann T, Ludwin S, Prat A, Antel J, Brück W, Lassmann H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathologica. PMID 27988845 DOI: 10.1007/s00401-016-1653-y |
0.32 |
|
| 2016 |
Torre S, Polyak MJ, Langlais D, Fodil N, Kennedy JM, Radovanovic I, Berghout J, Leiva-Torres GA, Krawczyk CM, Ilangumaran S, Mossman K, Liang C, Knobeloch KP, Healy LM, Antel J, ... ... Prat A, et al. Erratum: USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation. Nature Immunology. 17: 1479. PMID 27849203 DOI: 10.1038/ni1216-1479c |
0.52 |
|
| 2016 |
Torre S, Polyak MJ, Langlais D, Fodil N, Kennedy JM, Radovanovic I, Berghout J, Leiva-Torres GA, Krawczyk CM, Ilangumaran S, Mossman K, Liang C, Knobeloch KP, Healy LM, Antel J, ... ... Prat A, et al. USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation. Nature Immunology. PMID 27721430 DOI: 10.1038/ni.3581 |
0.8 |
|
| 2016 |
Lizak N, Lugaresi A, Alroughani R, Lechner-Scott J, Slee M, Havrdova E, Horakova D, Trojano M, Izquierdo G, Duquette P, Girard M, Prat A, Grammond P, Hupperts R, Grand'Maison F, et al. Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27683916 DOI: 10.1136/jnnp-2016-313976 |
0.56 |
|
| 2016 |
Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Girard M, Duquette P, Prat A, Lugaresi A, Grand'Maison F, Grammond P, Hupperts R, et al. Defining secondary progressive multiple sclerosis. Brain : a Journal of Neurology. PMID 27401521 DOI: 10.1093/brain/aww173 |
0.56 |
|
| 2016 |
Mayo L, Cunha AP, Madi A, Beynon V, Yang Z, Alvarez JI, Prat A, Sobel RA, Kobzik L, Lassmann H, Quintana FJ, Weiner HL. IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain : a Journal of Neurology. PMID 27246324 DOI: 10.1093/brain/aww113 |
0.8 |
|
| 2016 |
Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, Chao CC, Patel B, Yan R, Blain M, Alvarez JI, Kébir H, Anandasabapathy N, Izquierdo G, Jung S, ... ... Prat A, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nature Medicine. PMID 27158906 DOI: 10.1038/nm.4106 |
0.8 |
|
| 2016 |
Jokubaitis VG, Spelman T, Kalincik T, Lorscheider J, Havrdova E, Horakova D, Duquette P, Girard M, Prat A, Izquierdo G, Grammond P, Van Pesch V, Pucci E, Grand'Maison F, Hupperts R, et al. Predictors of long-term disability accrual in relapse-onset multiple sclerosis. Annals of Neurology. PMID 27145331 DOI: 10.1002/ana.24682 |
0.8 |
|
| 2016 |
Lévesque SA, Paré A, Mailhot B, Bellver-Landete V, Kébir H, Lécuyer MA, Alvarez JI, Prat A, Vaccari JP, Keane RW, Lacroix S. Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice. The Journal of Experimental Medicine. PMID 27139491 DOI: 10.1084/jem.20151437 |
0.8 |
|
| 2016 |
Spelman T, Kalincik T, Jokubaitis V, Zhang A, Pellegrini F, Wiendl H, Belachew S, Hyde R, Verheul F, Lugaresi A, Havrdová E, Horáková D, Grammond P, Duquette P, Prat A, et al. Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS. Neurology. Clinical Practice. 6: 102-115. PMID 27104064 DOI: 10.1212/CPJ.0000000000000227 |
0.8 |
|
| 2016 |
Stewart T, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Duquette P, Girard M, Prat A, Lugaresi A, Grand'Maison F, Grammond P, Sola P, Shaygannejad V, Hupperts R, et al. Contribution of different relapse phenotypes to disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27055805 DOI: 10.1177/1352458516643392 |
0.56 |
|
| 2016 |
Luo H, Broux B, Wang X, Hu Y, Ghannam S, Jin W, Larochelle C, Prat A, Wu J. EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurobiology of Disease. PMID 27039370 DOI: 10.1016/j.nbd.2016.03.013 |
0.8 |
|
| 2016 |
Larochelle C, Metz I, Lécuyer MA, Terouz S, Roger M, Arbour N, Brück W, Prat A. Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27037182 DOI: 10.1177/1352458516641775 |
0.52 |
|
| 2016 |
Larochelle C, Uphaus T, Prat A, Zipp F. Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology? Trends in Neurosciences. PMID 26987259 DOI: 10.1016/j.tins.2016.02.001 |
0.8 |
|
| 2016 |
Michel L, Prat A. One more role for the gut: microbiota and blood brain barrier. Annals of Translational Medicine. 4: 15. PMID 26855951 DOI: 10.3978/j.issn.2305-5839.2015.10.16 |
0.8 |
|
| 2016 |
Lécuyer MA, Kebir H, Prat A. Glial influences on BBB functions and molecular players in immune cell trafficking. Biochimica Et Biophysica Acta. 1862: 472-82. PMID 26454208 DOI: 10.1016/j.bbadis.2015.10.004 |
0.8 |
|
| 2015 |
Li R, Rezk A, Healy LM, Muirhead G, Prat A, Gommerman JL, Bar-Or A. Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis. Frontiers in Immunology. 6: 626. PMID 26779181 DOI: 10.3389/fimmu.2015.00626 |
0.8 |
|
| 2015 |
Alvarez JI, Kébir H, Cheslow L, Chabarati M, Larochelle C, Prat A. JAML mediates monocyte and CD8 T cell migration across the brain endothelium. Annals of Clinical and Translational Neurology. 2: 1032-7. PMID 26734656 DOI: 10.1002/acn3.255 |
0.56 |
|
| 2015 |
Michel L, Touil H, Pikor NB, Gommerman JL, Prat A, Bar-Or A. B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation. Frontiers in Immunology. 6: 636. PMID 26732544 DOI: 10.3389/fimmu.2015.00636 |
0.8 |
|
| 2015 |
Pikor NB, Astarita JL, Summers-Deluca L, Galicia G, Qu J, Ward LA, Armstrong S, Dominguez CX, Malhotra D, Heiden B, Kay R, Castanov V, Touil H, Boon L, O'Connor P, ... ... Prat A, et al. Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation. Immunity. 43: 1160-73. PMID 26682987 DOI: 10.1016/j.immuni.2015.11.010 |
0.8 |
|
| 2015 |
Sénécal V, Deblois G, Beauseigle D, Schneider R, Brandenburg J, Newcombe J, Moore CS, Prat A, Antel J, Arbour N. Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses. Glia. PMID 26649511 DOI: 10.1002/glia.22948 |
0.52 |
|
| 2015 |
Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, Moore CS, Michel L, Althekair F, Rajasekharan S, Gommerman JL, Prat A, Fillatreau S, Bar-Or A. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Science Translational Medicine. 7: 310ra166. PMID 26491076 DOI: 10.1126/scitranslmed.aab4176 |
0.8 |
|
| 2015 |
Kalincik T, Cutter G, Spelman T, Jokubaitis V, Havrdova E, Horakova D, Trojano M, Izquierdo G, Girard M, Duquette P, Prat A, Lugaresi A, Grand'Maison F, Grammond P, Hupperts R, et al. Defining reliable disability outcomes in multiple sclerosis. Brain : a Journal of Neurology. 138: 3287-98. PMID 26359291 DOI: 10.1093/brain/awv258 |
0.8 |
|
| 2015 |
Broux B, Gowing E, Prat A. Glial regulation of the blood-brain barrier in health and disease. Seminars in Immunopathology. 37: 577-90. PMID 26245144 DOI: 10.1007/s00281-015-0516-2 |
0.8 |
|
| 2015 |
Podjaski C, Alvarez JI, Bourbonniere L, Larouche S, Terouz S, Bin JM, Lécuyer MA, Saint-Laurent O, Larochelle C, Darlington PJ, Arbour N, Antel JP, Kennedy TE, Prat A. Netrin 1 regulates blood-brain barrier function and neuroinflammation. Brain : a Journal of Neurology. 138: 1598-612. PMID 25903786 DOI: 10.1093/brain/awv092 |
0.52 |
|
| 2015 |
Larochelle C, Lécuyer MA, Alvarez JI, Charabati M, Saint-Laurent O, Ghannam S, Kebir H, Flanagan K, Yednock T, Duquette P, Arbour N, Prat A. Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation. Annals of Neurology. 78: 39-53. PMID 25869475 DOI: 10.1002/ana.24415 |
0.8 |
|
| 2015 |
Legroux L, Pittet CL, Beauseigle D, Deblois G, Prat A, Arbour N. An optimized method to process mouse CNS to simultaneously analyze neural cells and leukocytes by flow cytometry. Journal of Neuroscience Methods. 247: 23-31. PMID 25819540 DOI: 10.1016/j.jneumeth.2015.03.021 |
0.8 |
|
| 2015 |
Michel L, Larochelle C, Prat A. Update on treatments in multiple sclerosis. Presse MéDicale (Paris, France : 1983). 44: e137-51. PMID 25813102 DOI: 10.1016/j.lpm.2015.02.008 |
0.8 |
|
| 2015 |
Daneman R, Prat A. The blood-brain barrier. Cold Spring Harbor Perspectives in Biology. 7: a020412. PMID 25561720 DOI: 10.1101/cshperspect.a020412 |
0.8 |
|
| 2015 |
Alvarez JI, Saint-Laurent O, Godschalk A, Terouz S, Briels C, Larouche S, Bourbonnière L, Larochelle C, Prat A. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions. Neurobiology of Disease. 74: 14-24. PMID 25448765 DOI: 10.1016/j.nbd.2014.09.016 |
0.8 |
|
| 2015 |
Duquette P, Prat A. How safe is natalizumab during pregnancy? Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 121-2. PMID 25392323 DOI: 10.1177/1352458514555789 |
0.8 |
|
| 2014 |
Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI, Mascanfroni ID, Yeste A, Kivisäkk P, Kallas K, Ellezam B, Bakshi R, Prat A, Antel JP, Weiner HL, et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nature Medicine. 20: 1147-56. PMID 25216636 DOI: 10.1038/nm.3681 |
0.8 |
|
| 2014 |
Miyazaki Y, Li R, Rezk A, Misirliyan H, Moore C, Farooqi N, Solis M, Goiry LG, de Faria Junior O, Dang VD, Colman D, Dhaunchak AS, Antel J, Gommerman J, Prat A, et al. A novel microRNA-132-surtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis. Plos One. 9: e105421. PMID 25136908 DOI: 10.1371/journal.pone.0105421 |
0.8 |
|
| 2014 |
Aubé B, Lévesque SA, Paré A, Chamma É, Kébir H, Gorina R, Lécuyer MA, Alvarez JI, De Koninck Y, Engelhardt B, Prat A, Côté D, Lacroix S. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases Journal of Immunology. 193: 2438-2454. PMID 25049355 DOI: 10.4049/jimmunol.1400401 |
0.8 |
|
| 2014 |
Larochelle C, Grand'maison F, Bernier GP, Latour M, Cailhier JF, Prat A. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1783-7. PMID 24534079 DOI: 10.1177/1352458514523692 |
0.8 |
|
| 2013 |
Schwartz M, Kipnis J, Rivest S, Prat A. How do immune cells support and shape the brain in health, disease, and aging? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 17587-96. PMID 24198349 DOI: 10.1523/JNEUROSCI.3241-13.2013 |
0.8 |
|
| 2013 |
Alvarez JI, Katayama T, Prat A. Glial influence on the blood brain barrier. Glia. 61: 1939-58. PMID 24123158 DOI: 10.1002/glia.22575 |
0.8 |
|
| 2013 |
Pickles S, Cadieux-Dion M, Alvarez JI, Lécuyer MA, Peyrard SL, Destroismaisons L, St-Onge L, Terouz S, Cossette P, Prat A, Vande Velde C. Endo-MitoEGFP mice: a novel transgenic mouse with fluorescently marked mitochondria in microvascular endothelial cells. Plos One. 8: e74603. PMID 24019971 DOI: 10.1371/journal.pone.0074603 |
0.8 |
|
| 2013 |
Brück W, Gold R, Lund BT, Oreja-Guevara C, Prat A, Spencer CM, Steinman L, Tintoré M, Vollmer TL, Weber MS, Weiner LP, Ziemssen T, Zamvil SS. Therapeutic decisions in multiple sclerosis: moving beyond efficacy. Jama Neurology. 70: 1315-24. PMID 23921521 DOI: 10.1001/jamaneurol.2013.3510 |
0.8 |
|
| 2013 |
Agrawal SM, Williamson J, Sharma R, Kebir H, Patel K, Prat A, Yong VW. Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis. Brain : a Journal of Neurology. 136: 1760-77. PMID 23687119 DOI: 10.1093/brain/awt093 |
0.8 |
|
| 2013 |
Freedman MS, Selchen D, Arnold DL, Prat A, Banwell B, Yeung M, Morgenthau D, Lapierre Y. Treatment optimization in MS: Canadian MS Working Group updated recommendations. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 40: 307-23. PMID 23603165 |
0.8 |
|
| 2013 |
Reijerkerk A, Lopez-Ramirez MA, van Het Hof B, Drexhage JA, Kamphuis WW, Kooij G, Vos JB, van der Pouw Kraan TC, van Zonneveld AJ, Horrevoets AJ, Prat A, Romero IA, de Vries HE. MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6857-63. PMID 23595744 DOI: 10.1523/JNEUROSCI.3965-12.2013 |
0.8 |
|
| 2013 |
Darlington PJ, Touil T, Doucet JS, Gaucher D, Zeidan J, Gauchat D, Corsini R, Kim HJ, Duddy M, Jalili F, Arbour N, Kebir H, Chen J, Arnold DL, Bowman M, ... ... Prat A, et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Annals of Neurology. 73: 341-54. PMID 23463494 DOI: 10.1002/ana.23784 |
0.8 |
|
| 2013 |
Zaguia F, Saikali P, Ludwin S, Newcombe J, Beauseigle D, McCrea E, Duquette P, Prat A, Antel JP, Arbour N. Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 190: 2510-8. PMID 23396942 DOI: 10.4049/jimmunol.1202725 |
0.8 |
|
| 2013 |
Mizee MR, Wooldrik D, Lakeman KA, van het Hof B, Drexhage JA, Geerts D, Bugiani M, Aronica E, Mebius RE, Prat A, de Vries HE, Reijerkerk A. Retinoic acid induces blood-brain barrier development. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 1660-71. PMID 23345238 DOI: 10.1523/JNEUROSCI.1338-12.2013 |
0.8 |
|
| 2013 |
Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR, Prat A, Scarpa M, Smeyne RJ, Drewes LR, Neuwelt EA. Immunologic privilege in the central nervous system and the blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 13-21. PMID 23072749 DOI: 10.1038/jcbfm.2012.153 |
0.8 |
|
| 2012 |
Larochelle C, Cayrol R, Kebir H, Alvarez JI, Lécuyer MA, Ifergan I, Viel É, Bourbonnière L, Beauseigle D, Terouz S, Hachehouche L, Gendron S, Poirier J, Jobin C, Duquette P, ... ... Prat A, et al. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain : a Journal of Neurology. 135: 2906-24. PMID 22975388 DOI: 10.1093/brain/aws212 |
0.8 |
|
| 2012 |
Flanagan K, Fitzgerald K, Baker J, Regnstrom K, Gardai S, Bard F, Mocci S, Seto P, You M, Larochelle C, Prat A, Chow S, Li L, Vandevert C, Zago W, et al. Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS. Plos One. 7: e40443. PMID 22792325 DOI: 10.1371/journal.pone.0040443 |
0.8 |
|
| 2012 |
Zhang MA, Rego D, Moshkova M, Kebir H, Chruscinski A, Nguyen H, Akkermann R, Stanczyk FZ, Prat A, Steinman L, Dunn SE. Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proceedings of the National Academy of Sciences of the United States of America. 109: 9505-10. PMID 22647601 DOI: 10.1073/pnas.1118458109 |
0.8 |
|
| 2012 |
Berard JL, Zarruk JG, Arbour N, Prat A, Yong VW, Jacques FH, Akira S, David S. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia. 60: 1145-59. PMID 22499213 DOI: 10.1002/glia.22342 |
0.8 |
|
| 2012 |
Prat A, Stüve O. Firategrast: natalizumab in a pill? The Lancet. Neurology. 11: 120-1. PMID 22226930 DOI: 10.1016/S1474-4422(11)70306-4 |
0.8 |
|
| 2011 |
Ifergan I, Kebir H, Terouz S, Alvarez JI, Lécuyer MA, Gendron S, Bourbonnière L, Dunay IR, Bouthillier A, Moumdjian R, Fontana A, Haqqani A, Klopstein A, Prinz M, López-Vales R, ... ... Prat A, et al. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions. Annals of Neurology. 70: 751-63. PMID 22162058 DOI: 10.1002/ana.22519 |
0.8 |
|
| 2011 |
Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L, Bernard M, van Horssen J, de Vries HE, Charron F, Prat A. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science (New York, N.Y.). 334: 1727-31. PMID 22144466 DOI: 10.1126/science.1206936 |
0.8 |
|
| 2011 |
Pittet CL, Newcombe J, Prat A, Arbour N. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis. Journal of Neuroinflammation. 8: 155. PMID 22067141 DOI: 10.1186/1742-2094-8-155 |
0.52 |
|
| 2011 |
Ifergan I, Kebir H, Alvarez JI, Marceau G, Bernard M, Bourbonnière L, Poirier J, Duquette P, Talbot PJ, Arbour N, Prat A. Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on α4 integrin. Brain : a Journal of Neurology. 134: 3560-77. PMID 22058139 DOI: 10.1093/brain/awr268 |
0.8 |
|
| 2011 |
Schneider R, Mohebiany AN, Ifergan I, Beauseigle D, Duquette P, Prat A, Arbour N. B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients. Journal of Immunology (Baltimore, Md. : 1950). 187: 4119-28. PMID 21911607 DOI: 10.4049/jimmunol.1100885 |
0.8 |
|
| 2011 |
Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? Febs Letters. 585: 3770-80. PMID 21550344 DOI: 10.1016/j.febslet.2011.04.066 |
0.8 |
|
| 2011 |
Prat A. Special issue on molecular basis of multiple sclerosis. Biochimica Et Biophysica Acta. 1812: 131. PMID 21168062 DOI: 10.1016/j.bbadis.2010.12.003 |
0.8 |
|
| 2011 |
Cayrol R, Haqqani AS, Ifergan I, Dodelet-Devillers A, Prat A. Isolation of human brain endothelial cells and characterization of lipid raft-associated proteins by mass spectroscopy. Methods in Molecular Biology (Clifton, N.J.). 686: 275-95. PMID 21082377 DOI: 10.1007/978-1-60761-938-3_13 |
0.8 |
|
| 2011 |
Alvarez JI, Cayrol R, Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochimica Et Biophysica Acta. 1812: 252-64. PMID 20619340 DOI: 10.1016/j.bbadis.2010.06.017 |
0.8 |
|
| 2010 |
Alvarez J, Dodelet-Devillers A, Ifergan I, Kebir H, Sabbagh M, Wosik K, de Vries E, van Horssen J, Fabre P, Charron F, Prat A. The Hedgehog Pathway Sustains Blood–brain Barrier Properties and Promotes CNS Immune Quiescence Clinical Immunology. 135: S68. DOI: 10.1016/j.clim.2010.03.208 |
0.8 |
|
| 2009 |
Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Annals of Neurology. 66: 390-402. PMID 19810097 DOI: 10.1002/ana.21748 |
0.8 |
|
| 2009 |
Schulze-Topphoff U, Prat A, Prozorovski T, Siffrin V, Paterka M, Herz J, Bendix I, Ifergan I, Schadock I, Mori MA, Van Horssen J, Schröter F, Smorodchenko A, Han MH, Bader M, et al. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nature Medicine. 15: 788-93. PMID 19561616 DOI: 10.1038/nm.1980 |
0.8 |
|
| 2009 |
Dodelet-Devillers A, Cayrol R, van Horssen J, Haqqani AS, de Vries HE, Engelhardt B, Greenwood J, Prat A. Functions of lipid raft membrane microdomains at the blood-brain barrier. Journal of Molecular Medicine (Berlin, Germany). 87: 765-74. PMID 19484210 DOI: 10.1007/s00109-009-0488-6 |
0.8 |
|
| 2009 |
Chintawar S, Cayrol R, Antel J, Pandolfo M, Prat A. Blood-brain barrier promotes differentiation of human fetal neural precursor cells. Stem Cells (Dayton, Ohio). 27: 838-46. PMID 19350685 DOI: 10.1002/stem.25 |
0.8 |
|
| 2008 |
Vincent T, Saikali P, Cayrol R, Roth AD, Bar-Or A, Prat A, Antel JP. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. Journal of Immunology (Baltimore, Md. : 1950). 181: 5730-7. PMID 18832732 |
0.8 |
|
| 2008 |
Niemelä J, Ifergan I, Yegutkin GG, Jalkanen S, Prat A, Airas L. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. European Journal of Immunology. 38: 2718-26. PMID 18825744 DOI: 10.1002/eji.200838437 |
0.8 |
|
| 2008 |
Cailhier JF, Sirois I, Laplante P, Lepage S, Raymond MA, Brassard N, Prat A, Iozzo RV, Pshezhetsky AV, Hébert MJ. Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. The Journal of Biological Chemistry. 283: 27220-9. PMID 18658137 DOI: 10.1074/jbc.M801164200 |
0.8 |
|
| 2008 |
Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, Haqqani AS, Kreymborg K, Krug S, Moumdjian R, Bouthillier A, Becher B, Arbour N, David S, Stanimirovic D, ... Prat A, et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nature Immunology. 9: 137-45. PMID 18157132 DOI: 10.1038/ni1551 |
0.8 |
|
| 2008 |
Ifergan I, Kébir H, Bernard M, Wosik K, Dodelet-Devillers A, Cayrol R, Arbour N, Prat A. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain : a Journal of Neurology. 131: 785-99. PMID 18156156 DOI: 10.1093/brain/awm295 |
0.8 |
|
| 2007 |
Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nature Medicine. 13: 1173-5. PMID 17828272 DOI: 10.1038/nm1651 |
0.8 |
|
| 2007 |
Jack CS, Arbour N, Blain M, Meier UC, Prat A, Antel JP. Th1 polarization of CD4+ T cells by Toll-like receptor 3-activated human microglia. Journal of Neuropathology and Experimental Neurology. 66: 848-59. PMID 17805015 DOI: 10.1097/nen.0b013e3181492a7 |
0.52 |
|
| 2007 |
Wosik K, Cayrol R, Dodelet-Devillers A, Berthelet F, Bernard M, Moumdjian R, Bouthillier A, Reudelhuber TL, Prat A. Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 9032-42. PMID 17715340 DOI: 10.1523/JNEUROSCI.2088-07.2007 |
0.8 |
|
| 2007 |
Wosik K, Biernacki K, Khouzam MP, Prat A. Death receptor expression and function at the human blood brain barrier. Journal of the Neurological Sciences. 259: 53-60. PMID 17395209 DOI: 10.1016/j.jns.2006.08.018 |
0.8 |
|
| 2007 |
Lee G, Babakhanian K, Ramaswamy M, Prat A, Wosik K, Bendayan R. Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems. Pharmaceutical Research. 24: 1262-74. PMID 17380269 DOI: 10.1007/s11095-007-9244-1 |
0.8 |
|
| 2007 |
Saikali P, Antel JP, Newcombe J, Chen Z, Freedman M, Blain M, Cayrol R, Prat A, Hall JA, Arbour N. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1220-8. PMID 17267578 DOI: 10.1523/JNEUROSCI.4402-06.2007 |
0.8 |
|
| 2006 |
Ifergan I, Wosik K, Cayrol R, Kébir H, Auger C, Bernard M, Bouthillier A, Moumdjian R, Duquette P, Prat A. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Annals of Neurology. 60: 45-55. PMID 16729291 DOI: 10.1002/ana.20875 |
0.8 |
|
| 2005 |
Prat A, Antel J. Pathogenesis of multiple sclerosis. Current Opinion in Neurology. 18: 225-30. PMID 15891404 |
0.8 |
|
| 2005 |
Prat A, Biernacki K, Antel JP. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1. Journal of Autoimmunity. 24: 119-24. PMID 15829404 DOI: 10.1016/j.jaut.2005.01.004 |
0.8 |
|
| 2004 |
Biernacki K, Prat A, Blain M, Antel JP. Regulation of cellular and molecular trafficking across human brain endothelial cells by Th1- and Th2-polarized lymphocytes. Journal of Neuropathology and Experimental Neurology. 63: 223-32. PMID 15055446 |
0.8 |
|
| 2003 |
Séguin R, Biernacki K, Rotondo RL, Prat A, Antel JP. Regulation and functional effects of monocyte migration across human brain-derived endothelial cells. Journal of Neuropathology and Experimental Neurology. 62: 412-9. PMID 12722833 |
0.8 |
|
| 2003 |
Alter A, Duddy M, Hebert S, Biernacki K, Prat A, Antel JP, Yong VW, Nuttall RK, Pennington CJ, Edwards DR, Bar-Or A. Determinants of human B cell migration across brain endothelial cells. Journal of Immunology (Baltimore, Md. : 1950). 170: 4497-505. PMID 12707326 |
0.8 |
|
| 2003 |
Séguin R, Biernacki K, Prat A, Wosik K, Kim HJ, Blain M, McCrea E, Bar-Or A, Antel JP. Differential effects of Th1 and Th2 lymphocyte supernatants on human microglia. Glia. 42: 36-45. PMID 12594735 DOI: 10.1002/glia.10201 |
0.56 |
|
| 2003 |
Séguin R, Moditi Z, Rotondo R, Biernacki K, Wosik K, Prat A, Antel JP. Human brain endothelial cells supply support for monocyte immunoregulatory functions. Journal of Neuroimmunology. 135: 96-106. PMID 12576229 |
0.56 |
|
| 2002 |
Prat A, Biernacki K, Lavoie JF, Poirier J, Duquette P, Antel JP. Migration of multiple sclerosis lymphocytes through brain endothelium. Archives of Neurology. 59: 391-7. PMID 11890842 |
0.56 |
|
| 2001 |
Biernacki K, Prat A, Blain M, Antel JP. Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells Journal of Neuropathology and Experimental Neurology. 60: 1127-1136. PMID 11764086 |
0.8 |
|
| 2001 |
Pouly S, Prat A, Blain M, Olivier A, Antel J. NG2 immunoreactivity on human brain endothelial cells Acta Neuropathologica. 102: 313-320. PMID 11603805 |
0.8 |
|
| 2001 |
Prat A, Biernacki K, Wosik K, Antel JP. Glial cell influence on the human blood-brain barrier Glia. 36: 145-155. PMID 11596123 DOI: 10.1002/glia.1104 |
0.8 |
|
| 2001 |
Calabresi PA, Prat A, Biernacki K, Rollins J, Antel JP. T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells. Journal of Neuroimmunology. 115: 161-7. PMID 11282166 DOI: 10.1016/S0165-5728(01)00253-3 |
0.8 |
|
| 2000 |
Prat A, Biernacki K, Pouly S, Nalbantoglu J, Couture R, Antel JP. Kinin B1 receptor expression and function on human brain endothelial cells Journal of Neuropathology and Experimental Neurology. 59: 896-906. PMID 11079780 DOI: 10.1093/jnen/59.10.896 |
0.8 |
|
| 2000 |
Qin Y, Zhang DQ, Prat A, Pouly S, Antel J. Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients Journal of Neuroimmunology. 108: 201-206. PMID 10900354 DOI: 10.1016/S0165-5728(00)00263-0 |
0.8 |
|
| 2000 |
Antel J, Prat A. Antigen and superantigen presentation in the human CNS Journal of Neuroimmunology. 107: 118-123. PMID 10854645 DOI: 10.1016/S0165-5728(00)00229-0 |
0.8 |
|
| 2000 |
Prat A, Biernacki K, Becher B, Antel JP. B7 expression and antigen presentation by human brain endothelial cells: Requirement for proinflammatory cytokines Journal of Neuropathology and Experimental Neurology. 59: 129-136. PMID 10749102 |
0.8 |
|
| 2000 |
Prat A, Pelletier D, Duquette P, Arnold DL, Antel JP. Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: Relation to magnetic resonance imaging lesion volume Annals of Neurology. 47: 234-237. PMID 10665495 DOI: 10.1002/1531-8249(200002)47:2<234::AID-ANA14>3.0.CO;2-S |
0.8 |
|
| 2000 |
Becher B, Prat A, Antel JP. Brain-immune connection: Immuno-regulatory properties of CNS-resident cells Glia. 29: 293-304. PMID 10652440 DOI: 10.1002/(SICI)1098-1136(20000215)29:4<293::AID-GLIA1>3.0.CO;2-A |
0.8 |
|
| 1999 |
Prat A, Weinrib L, Becher B, Poirier J, Duquette P, Couture R, Antel JP. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis Neurology. 53: 2087-2092. PMID 10599786 DOI: 10.1212/WNL.53.9.2087 |
0.8 |
|
| 1999 |
Prat A, Al-Asmi A, Duquette P, Antel JP. Lymphocyte migration and multiple sclerosis: Relation with disease course and therapy Annals of Neurology. 46: 253-256. PMID 10443892 DOI: 10.1002/1531-8249(199908)46:2<253::AID-ANA16>3.0.CO;2-C |
0.8 |
|
| 1995 |
Couture R, Picard P, Poulat P, Prat A. Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation Canadian Journal of Physiology and Pharmacology. 73: 892-902. PMID 8846427 |
0.8 |
|
| 1994 |
Prat A, Picard P, Couture R. Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: Receptor characterization British Journal of Pharmacology. 112: 250-256. PMID 7518305 |
0.8 |
|
| 1993 |
Prat A, Picard P, Domenico R, Couture R. Characterization of the cardiovascular and behavioral effects of centrally administered neuropeptide K in the conscious rat Regulatory Peptides. 46: 317-320. PMID 8210496 DOI: 10.1016/0167-0115(93)90072-G |
0.8 |
|
| 1993 |
Prat A, Hasséssian H, Couture R. Neuropeptide K potently stimulates the hydrolysis of phosphatidylinositol in the rat spinal cord Neuroscience Letters. 159: 95-98. PMID 7505418 DOI: 10.1016/0304-3940(93)90807-W |
0.8 |
|
| 1992 |
Hasséssian H, Prat A, Couture R. Anaesthetic doses of pentobarbital antagonize phosphatidylinositol hydrolysis induced by substance P or carbachol in the spinal cord and cerebral cortex of the rat European Journal of Pharmacology: Molecular Pharmacology. 227: 103-107. PMID 1385186 DOI: 10.1016/0922-4106(92)90150-T |
0.8 |
|
| 1991 |
Hasséssian H, Prat A, De Champlain J, Couture R. Regulation of cardiovascular sympathetic neurons by substance P and γ-aminobutyric acid in the rat spinal cord European Journal of Pharmacology. 202: 51-60. PMID 1723952 DOI: 10.1016/0014-2999(91)90252-L |
0.8 |
|
| Show low-probability matches. |